Eddie Blair, CEO, GeneFirst, a biotech in the business of modernising molecular diagnostics, spoke to me about his funding strategy and how he is addressing the challenges. He is using…
Continue reading
Malcolm Young, CEO of e-therapeutics and a network pharmacologist, spoke to me about his concerns for the industry. Out of all of them, one stood out in particular. Understanding the…
Continue readingEddie Blair, CEO, GeneFirst, a biotech in the business of modernising molecular diagnostics, spoke to me about his funding strategy and how he is addressing the challenges. He is using…
Continue reading